Cookies: Information & Consent

We have placed cookies on your device to help make this website better. Some of the cookies we use are essential for this site to work. We also use some non-essential cookies to collect information for making reports and to help us improve the site. You will find more detailled information in our Privacy Chart.

March 2020

Banook Group welcomes Turenne Santé as new investor, alongside the management

Funds obtained will enable the European leader in cardiac safety to continue its…
Read the full post
May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018  6:00 PM CEST (Central European Time) UTC/GMT + 2…
Read the full post
April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018 

6:00 PM CEST (Central European Time) UTC/GMT + 2 hours


Duration: 1 hour


Presented by:

Paul Dorian – MD, PhD – Division of Cardiology at University of Toronto

Etienne Aliot – MD, PhD – Chief Medical Officer Banook Group


Session #1

Novel smart cardiac monitoring technologies for Clinical Trials: a state-of-art review.


The increasing popularity of new biosensors has opened up several opportunities for the management of cardiac end points during clinical trials. The purpose of this presentation is to assess the role and utility of these novel technologies in the cardiac safety and rhythm assessment. The lecture will cover the benefits and constraints of implanted devices, wearable sensors, connected devices…including the added value of patient friendly diagnostics systems.


Session #2

How to deal with Wearables Cardiac Biosensors in Clinical Trials? Two practical uses cases.


This presentation will assess the (im)possibilities and design of clinical trials that intent to use wearable cardiac biosensor as method of choice for safety or Atrial Fibrillation assessment. Two concrete uses cases will be covered including the use of a mobile ECG heart monitor and a long-term cable-free ECG recording system.


Reserve your webinar seat now

After registering you will receive a confirmation email containing information about joining the Webinar.


About the Presenters :

Professor Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael’s Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto, and a Staff Scientist at the Li Ka Shing Knowledge Institute. His research interests include basic science research in advanced cardiac life support and atrial fibrillation, the clinical pharmacology of antiarrhythmic drugs, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias.


Professor Etienne Aliot is the former head of the “Cardio Medico Surgical Center” of the University hospital of Nancy (France). He has extensive experience in scientific, clinical and regulatory aspects of cardiology practice acting as chairman of the Working Group on Arrhythmias of the European Society of Cardiology and Member of the Board the French Federation of Cardiology. He has participated in several scientific committee or DSMB of major randomized controlled trials.


To know more about Banook Group :